Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07725822 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Modern Research Associates, PLLC

Record History

  1. Notable Recruitment opened Start date changed from estimate of Aug 2026 to Sep 15, 2026 · Eligibility criteria expanded, about 37 words · Site details revised Show 3 more changesShow less
    • Start date changed from estimate of Aug 2026 to Sep 15, 2026
    • Eligibility criteria expanded, about 37 words
    • Site details revised
  2. Notable Primary endpoint(s) modified Eligibility criteria shortened, about 28 wordsv2 Show 1 more changeShow less
    • Eligibility criteria shortened, about 28 words

    See this version in full on ClinicalTrials.gov ↗

  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open label trial in subjects ≥12 years of age and older with chronic plaque psoriasis and moderate to severe nail psoriasis. Eligible participants will apply roflumilast 0.3% cream daily for 24 weeks to affected nails daily for the entire study duration and to psoriasis plaques daily until clear.
Trial Details
NCT Number NCT07725822
Lead Sponsor Modern Research Associates, PLLC
Conditions Chronic Plaque Psoriasis, Nail Psoriasis
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov